Calcitonin (Salmon) EP Impurity D represents a structurally related variant of salmon calcitonin observed in analytical profiling. Residue or linkage modifications affect helix stability, disulfide geometry, and chromatographic mobility. Researchers utilize it as a standard for impurity quantitation. Applications include stability-indicating method development, process characterization, and structural-comparison studies.
CAT No: R2751
Calcitonin(salmon) EP Impurity D is a synthetic peptide impurity structurally related to salmon calcitonin, a well-characterized hormone involved in calcium homeostasis. As a defined peptide fragment, this compound is of significant interest in the context of peptide drug development, quality control, and analytical method validation. Its unique sequence and structural features make it a valuable reference standard for distinguishing between the principal active pharmaceutical ingredient and its process- or degradation-related impurities. The availability of such peptide impurities supports rigorous scientific investigation into the stability, purity, and integrity of calcitonin-based formulations, ensuring the reliability of research and manufacturing processes.
Analytical method development: The peptide fragment serves as a critical reference material for developing and validating analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry. By providing a well-defined standard, it enables accurate identification and quantification of process-related impurities in salmon calcitonin preparations. This is essential for establishing robust quality control protocols and ensuring the specificity and sensitivity of analytical assays used in peptide characterization.
Pharmaceutical impurity profiling: In the context of peptide drug manufacturing, the presence and quantification of related impurities are closely monitored to assess product consistency and safety. Calcitonin(salmon) EP Impurity D is employed as a benchmark impurity for impurity profiling studies, facilitating the assessment of degradation pathways, process optimization, and the elucidation of impurity formation mechanisms. Its use aids researchers in differentiating between genuine active peptide and structurally similar by-products, supporting comprehensive impurity mapping.
Peptide stability studies: The synthetic impurity is instrumental in forced degradation and stability testing experiments, where it acts as a marker for tracking the formation and evolution of peptide-related impurities under various stress conditions. By monitoring the appearance and concentration of this fragment, researchers can evaluate the degradation kinetics of salmon calcitonin formulations, predict shelf-life, and optimize storage conditions. Such studies are fundamental for ensuring the long-term stability and reliability of peptide-based products.
Peptide synthesis process optimization: The presence of defined impurities such as this peptide fragment provides valuable feedback for refining solid-phase peptide synthesis protocols. By analyzing the occurrence and levels of Impurity D during different stages of synthesis and purification, chemists can identify critical control points, improve reaction conditions, and enhance overall process yields. This informs the development of more efficient and reproducible manufacturing strategies for complex peptide drugs.
Reference standard for regulatory documentation: Although not for clinical or therapeutic use, this compound is often utilized as a reference standard in the preparation of regulatory submissions and technical dossiers. Its inclusion allows for comprehensive documentation of impurity profiles, supporting the demonstration of product quality and consistency to regulatory authorities. The use of well-characterized peptide impurities in such contexts underscores a commitment to scientific rigor and compliance with industry best practices.
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More